PA
Peter Altman
President and CEODirector

Peter Altman insider trades: BioCardia (BCDA) stock buys and sales

President and CEO, BioCardia Last trade Oct 16, 2026 118 Form 4 filings
$0
Sold, last 12 months
0 sales
$65K
Bought, last 12 months
21 buys
99
Open-market trades
since 2018
2
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Peter reports to the SEC

BCDA
BCDABioCardia
President and CEO · last filing Oct 20, 2026
+$368K
BCDA;BCDAWBioCardia
President and CEO · last filing Jul 2, 2024
-$7K
+$245K

Open-market buys and sales

99 trades reported on SEC Form 4, newest first

DateStockTypeValue
Oct 16, 2026BCDA↑ Buy$475
Sep 29, 2026BCDA↑ Buy$1K
Sep 23, 2026BCDA↑ Buy$2K
Sep 3, 2026BCDA↑ Buy$872
Aug 17, 2026BCDA↑ Buy$5K
Aug 13, 2026BCDA↑ Buy$2K
Jul 29, 2026BCDA↑ Buy$4K
Jul 17, 2026BCDA↑ Buy$415
Jul 15, 2026BCDA↑ Buy$4K
Jul 10, 2026BCDA↑ Buy$7K
Jul 8, 2026BCDA↑ Buy$5K
Jun 18, 2026BCDA↑ Buy$2K
Jun 9, 2026BCDA↑ Buy$4K
May 20, 2026BCDA↑ Buy$2K
May 18, 2026BCDA↑ Buy$5K
May 15, 2026BCDA↑ Buy$5K
Apr 29, 2026BCDA↑ Buy$6K
Apr 21, 2026BCDA↑ Buy$1K
Feb 4, 2026BCDA↑ Buy$6K
Jan 21, 2026BCDA↑ Buy$1K
Dec 17, 2025BCDA↑ Buy$1K
Sep 19, 2025BCDA↑ Buy$60K
Aug 22, 2025BCDA↑ Buy$1K
Aug 13, 2025BCDA↑ Buy$183
Aug 12, 2025BCDA↑ Buy$700
Aug 11, 2025BCDA↑ Buy$3K
Jun 30, 2025BCDA↑ Buy$50K
May 30, 2025BCDA↑ Buy$221
May 22, 2025BCDA↑ Buy$5K
May 16, 2025BCDA↑ Buy$1K
Apr 23, 2025BCDA↑ Buy$50K
Apr 15, 2025BCDA↑ Buy$214
Apr 11, 2025BCDA↑ Buy$1K
Apr 7, 2025BCDA↑ Buy$980
Apr 4, 2025BCDA↑ Buy$2K
Apr 3, 2025BCDA↑ Buy$2K
Apr 3, 2025BCDA↑ Buy$3K
Mar 3, 2025BCDA↑ Buy$1K
Feb 7, 2025BCDA↑ Buy$1K
Jan 30, 2025BCDA↑ Buy$2K
Dec 23, 2024BCDA↑ Buy$2K
Dec 5, 2024BCDA↑ Buy$555
Nov 15, 2024BCDA↑ Buy$3K
Jul 1, 2024BCDA;BCDAW↑ Buy$2K
Jun 21, 2024BCDA;BCDAW↑ Buy$2K
Jun 14, 2024BCDA;BCDAW↑ Buy$2K
Jun 10, 2024BCDA;BCDAW↑ Buy$3K
Apr 19, 2024BCDA;BCDAW↑ Buy$1K
Mar 28, 2024BCDA;BCDAW↑ Buy$195
Feb 13, 2024BCDA;BCDAW↑ Buy$50K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other BCDA insiders

Open-market trades in the last 12 months

About Peter Altman's insider trades

Peter Altman is President and CEO at BioCardia (BCDA). Since Mar 20, 2018, Peter has reported 98 open-market purchases worth $614K and 1 sale worth $7K on SEC Form 4. In the last 12 months: 21 buys ($65K).

Their filings also include grants and awards (16 filings), shares withheld for taxes (8 filings), other transactions (5 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BCDA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.